Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

Core Insights - Heron Therapeutics, Inc. has appointed Thomas Cusack to its Board of Directors, enhancing its governance and strategic direction [1][2] - Mr. Cusack brings over 20 years of experience in investment management and corporate finance, previously serving as Managing Director at Starboard Value LP [2] - The appointment is part of a Cooperation Agreement with Rubric Capital Management LP, indicating a strategic partnership aimed at improving company performance [1][2] Company Overview - Heron Therapeutics is a commercial-stage biotechnology company focused on developing therapeutic innovations to enhance patient care [3] - The company utilizes advanced science and patented technologies to create a portfolio of products aimed at improving standards of care for acute care and oncology patients [3]